Traditional Medicinal Plants Used in Children’s Healthcare in Sub-Saharan Africa: A Scoping Review of Safety, Toxicity and Adverse Effects
Molecules · 19.11.2026 · 31 (22) · 4214
DOI: 10.3390/molecules31224214 ↗Kurz gefasst
Scoping Review in der Zeitschrift Molecules, online erschienen am 19.11.2026. Verfasst von Khavharendwe Muriel Mudau und 3 weiteren Autor:innen. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
The use of medicinal plant remedies in children’s healthcare across sub-Saharan Africa raises concerns regarding their safety, as these remedies may contain bioactive compounds that may cause toxicity in children. Therefore, the review aimed to evaluate available literature on the ethnomedicinal uses, toxicity, and adverse effects of medicinal plants used in children’s healthcare in sub-Saharan Africa. This scoping review was guided by Arksey and O’Malley framework. The review identified and analysed only 21 relevant studies from 9 countries, which reveals a limited and geographically uneven evidence base for the region. A total of 29 medicinal plants were reported to be toxic, with leaves and roots being the most commonly used plant parts. These plants were used to treat malaria, gastrointestinal problems, skin conditions, wounds, and respiratory infections. Reported toxic effects included hepatotoxicity, nephrotoxicity, and neurotoxicity, while common clinical adverse effects included diarrhoea, vomiting, and abdominal pain. Plants such as Euphorbia candelabrum, Amanita muscaria, Acokanthera schimperi were reported to cause fatal toxicity. Pyrrolizidine alkaloids were the most reported toxic compounds identified in the documented medicinal plants. The results of the review provide a preliminary overview of the safety profiles of medicinal plants used for children’s healthcare in sub-Saharan Africa and reveal substantial knowledge gaps across the region. However, in many sub-Saharan African regions, underreporting, weak regulation, and safety monitoring may increase adverse effects. Therefore, strengthening pharmacovigilance, standardisation, and toxicological evaluation is essential to promote the safe and effective use of traditional medicinal plants.
Förderung
- National Research Foundation
Zitieren
APA
Mudau, K. M., Magwalivha, M., Sigidi, M., & Nethathe, B. (2026). Traditional Medicinal Plants Used in Children’s Healthcare in Sub-Saharan Africa: A Scoping Review of Safety, Toxicity and Adverse Effects. Molecules, 31(22), 4214. https://doi.org/10.3390/molecules31224214
Vancouver
Mudau KM, Magwalivha M, Sigidi M, Nethathe B. Traditional Medicinal Plants Used in Children’s Healthcare in Sub-Saharan Africa: A Scoping Review of Safety, Toxicity and Adverse Effects. Molecules. 2026;31(22):4214. doi:10.3390/molecules31224214
BibTeX
@article{Mudau2026,
author = {Mudau, Khavharendwe Muriel and Magwalivha, Mpho and Sigidi, Muendi and Nethathe, Bono},
title = {Traditional Medicinal Plants Used in Children’s Healthcare in Sub-Saharan Africa: A Scoping Review of Safety, Toxicity and Adverse Effects},
journal = {Molecules},
year = {2026},
volume = {31},
number = {22},
pages = {4214},
doi = {10.3390/molecules31224214}
}
EUVIMED